Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Decide which cash back credit card you should get by assessing your spending habits. Find the best rewards for you.
14,029 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
With $5,000, you can build a solid starter portfolio that balances growth and risk. This guide shows a simple, repeat...
European Union and United States trade talks accelerate, threatening tariff changes that could ripple through inflati...
NVIDIA gains from a limited export-license shift that allows select Chinese firms to buy its top AI accelerators, but...
A two-week surge from late April to mid-May 2026 rewired listing data, with private networks expanding and major brok...
A federal court faces a pivotal deadline on whether Zillow can maintain access to MRED listings amid an antitrust dis...
A rapid AI-driven capex cycle is widening the performance split between cap-weighted and equal-weight NASDAQ funds, u...
XRP trades in a tight band around $1.40 as traders weigh regulatory progress, ETF flows, and Bitcoin momentum. This r...
The Coinbase-backed Base blockchain introduces an MCP gateway that lets users control on-chain actions with natural l...
Palo Alto Networks’ stock fell after the latest earnings, as traders weighed a murky near-term outlook against the co...
A global race to control a nascent $320 billion brain-implant market pits Elon Musk and Sam Altman against Chinese ri...
Traders chase BOIL as natural gas whipsaws drive outsized moves, despite heavy losses over the past year. The 2x leve...